Breast Cancer Journal Club

F. Cardoso, L. J. Van’t Veer, J. Bogaerts, et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. New England Journal of Medicine. 2016;375:717-729. doi:10.1056/nejmoa1602253

Diskin B, Sevilimedu V, Morrow M, Van Zee K, Cody HS 3rd. Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor Zone. Ann Surg Oncol. 2024;31(13):8843-8847. doi:10.1245/s10434-024-16133-8

Vicini F, Shah C, Mittal K, et al. Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates. International Journal of Radiation Oncology, Biology, Physics. January 2025. doi:10.1016/j.ijrobp.2025.07.1411